Preliminary experiments suggest conolidine could inhibit specific ion channels, decreasing neuronal excitability and limiting pain alerts. This mechanism is particularly applicable in neuropathic suffering, where by irregular signaling will cause persistent irritation. Furthermore, conolidine appears to impact G protein-coupled receptor (GPCR) pathways integral to suffering perception... https://tinar940gms4.blogtov.com/profile